Application of GQSAR for Scaffold Hopping and Lead Optimization in Multitarget Inhibitors

被引:18
作者
Ajmani, Subhash [1 ]
Kulkarni, Sudhir A. [1 ,2 ]
机构
[1] NovaLead Pharma Pvt Ltd, Pride Purple Coronet, Pune 411045, Maharashtra, India
[2] VLife Sci Technol Pvt Ltd, Pride Purple Coronet, Pune 411045, Maharashtra, India
关键词
Group based QSAR; Scaffold hopping; Lead optimization; Multitarget inhibitors; DESIGNING MULTIPLE LIGANDS; PROTEIN-KINASE INHIBITORS; DRUG DISCOVERY; NETWORK PERSPECTIVES; REUPTAKE INHIBITORS; QSPR MODELS; MECHANISMS; DATABASE; QSAR; ANTIDEPRESSANTS;
D O I
10.1002/minf.201100160
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Many literature reports suggest that drugs against multiple targets may overcome many limitations of single targets and achieve a more effective and safer control of the disease. However, design of multitarget drugs presents a great challenge. The present study demonstrates application of a novel Group based QSAR (GQSAR) method to assist in lead optimization of multikinase (PDGFR-beta, FGFR-1 and SRC) and scaffold hopping of multiserotonin target (serotonin receptor 1A and serotonin transporter) inhibitors. For GQSAR analysis, a wide variety of structurally diverse multikinase inhibitors (225 molecules) and multiserotonin target inhibitors (162 molecules) were collected from various literature reports. Each molecule in the data set was divided into four fragments (kinase inhibitors) and three fragments (serotonin target inhibitors) and their corresponding two-dimensional fragment descriptors were calculated. The multiresponse regression GQSAR models were developed for both the datasets. The developed GQSAR models were found to be useful for scaffold hopping and lead optimization of multitarget inhibitors. In addition, the developed GQSAR models provide important fragment based features that can form the building blocks to guide combinatorial library design in the search for optimally potent multitarget inhibitors.
引用
收藏
页码:473 / 490
页数:18
相关论文
共 50 条
[1]   A comprehensive structure-activity analysis of protein kinase B-alpha (Akt1) inhibitors [J].
Ajmani, Subhash ;
Agrawal, Avantika ;
Kulkarni, Sudhir A. .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2010, 28 (07) :683-694
[2]   Group-Based QSAR (G-QSAR): Mitigating Interpretation Challenges in QSAR [J].
Ajmani, Subhash ;
Jadhav, Kamalakar ;
Kulkarni, Sudhir A. .
QSAR & COMBINATORIAL SCIENCE, 2009, 28 (01) :36-51
[3]  
[Anonymous], 2008, VLIFEMDS VERS 3 5
[4]  
Atkinson Anthony Curtes, 1985, Plots, transformations and regression
[5]  
an introduction to graphical methods of diagnostic regression analysis
[6]   An alignment-independent versatile structure descriptor for QSAR and QSPR based on the distribution of molecular features [J].
Baumann, K .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2002, 42 (01) :26-35
[7]   The efficiency of multi-target drugs: the network approach might help drug design [J].
Csermely, P ;
Agoston, V ;
Pongor, S .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (04) :178-182
[8]   Issues and progress with protein kinase inhibitors for cancer treatment [J].
Dancey, J ;
Sausville, EA .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (04) :296-313
[9]   Fragment-based design, docking, synthesis, biological evaluation and structure-activity relationships of 2-benzo/benzisothiazolimino-5-aryliden-4-thiazolidinones as cycloxygenase/lipoxygenase inhibitors [J].
Eleftheriou, Phaedra ;
Geronikaki, Athina ;
Hadjipavlou-Litina, Dimitra ;
Vicini, Paola ;
Tarasova, Olga A. ;
Filimonov, Dmitry ;
Poroikov, Vladimir ;
Chaudhaery, Shailendra S. ;
Roy, Kuldeep K. ;
Saxena, Anil K. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 47 :111-124
[10]  
*FOOD DRUG ADM, 2004, INN STAG CHALL OPP C